Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism.

Linglart A, Rothenbuhler A, Gueorgieva I, Lucchini P, Silve C, Bougnères P.

J Clin Endocrinol Metab. 2011 Nov;96(11):3308-12. doi: 10.1210/jc.2011-1359. Epub 2011 Aug 24.

PMID:
21865375
[PubMed - indexed for MEDLINE]
2.

The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study.

Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L; Hypoparathyroid Study Group.

J Bone Miner Res. 2011 Oct;26(10):2358-70. doi: 10.1002/jbmr.470.

PMID:
21773992
[PubMed - indexed for MEDLINE]
3.

PTH treatment in hypoparathyroidism.

Sikjaer T, Rejnmark L, Mosekilde L.

Curr Drug Saf. 2011 Apr;6(2):89-99. Review.

PMID:
21524246
[PubMed - indexed for MEDLINE]
4.

Statistical methods for detecting and comparing periodic data and their application to the nycthemeral rhythm of bodily harm: A population based study.

Stroebel AM, Bergner M, Reulbach U, Biermann T, Groemer TW, Klein I, Kornhuber J.

J Circadian Rhythms. 2010 Nov 8;8:10. doi: 10.1186/1740-3391-8-10.

PMID:
21059197
[PubMed]
Free PMC Article
5.

Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.

Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr.

J Clin Endocrinol Metab. 2010 Jun;95(6):2680-8. doi: 10.1210/jc.2009-2464. Epub 2010 Apr 14.

PMID:
20392870
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Therapy of hypoparathyroidism with intact parathyroid hormone.

Rubin MR, Sliney J Jr, McMahon DJ, Silverberg SJ, Bilezikian JP.

Osteoporos Int. 2010 Nov;21(11):1927-34. doi: 10.1007/s00198-009-1149-x. Epub 2010 Jan 22.

PMID:
20094706
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Postoperative hypoparathyroidism: medical and surgical therapeutic options.

Walker Harris V, Jan De Beur S.

Thyroid. 2009 Sep;19(9):967-73. doi: 10.1089/thy.2008.0306.

PMID:
19731978
[PubMed - indexed for MEDLINE]
8.

Hypoparathyroidism: is it time for replacement therapy?

Horwitz MJ, Stewart AF.

J Clin Endocrinol Metab. 2008 Sep;93(9):3307-9. doi: 10.1210/jc.2008-1216. No abstract available.

PMID:
18772463
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.

Puig-Domingo M, Díaz G, Nicolau J, Fernández C, Rueda S, Halperin I.

Eur J Endocrinol. 2008 Nov;159(5):653-7. doi: 10.1530/EJE-08-0269. Epub 2008 Aug 14.

PMID:
18703565
[PubMed - indexed for MEDLINE]
Free Article
10.

Clinical practice. Hypoparathyroidism.

Shoback D.

N Engl J Med. 2008 Jul 24;359(4):391-403. doi: 10.1056/NEJMcp0803050. Review. No abstract available.

PMID:
18650515
[PubMed - indexed for MEDLINE]
11.

Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.

Winer KK, Sinaii N, Peterson D, Sainz B Jr, Cutler GB Jr.

J Clin Endocrinol Metab. 2008 Sep;93(9):3389-95. doi: 10.1210/jc.2007-2552. Epub 2008 May 20.

PMID:
18492754
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

On the interpretation of rat carcinogenicity studies for human PTH(1-34) and human PTH(1-84).

Tashjian AH Jr, Goltzman D.

J Bone Miner Res. 2008 Jun;23(6):803-11. doi: 10.1359/jbmr.080208. No abstract available.

PMID:
18435577
[PubMed - indexed for MEDLINE]
13.

Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.

Tashjian AH Jr, Gagel RF.

J Bone Miner Res. 2006 Mar;21(3):354-65. Epub 2005 Nov 11. Review. No abstract available.

PMID:
16491282
[PubMed - indexed for MEDLINE]
14.

On analyzing circadian rhythms data using nonlinear mixed models with harmonic terms.

Albert PS, Hunsberger S.

Biometrics. 2005 Dec;61(4):1115-20; discussion 1120-2.

PMID:
16401286
[PubMed - indexed for MEDLINE]
15.

Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review.

Quack I, Zwernemann C, Weiner SM, Sellin L, Henning BF, Waldherr R, Büchner NJ, Stegbauer J, Vonend O, Rump LC.

Exp Clin Endocrinol Diabetes. 2005 Jul;113(7):376-80. Review.

PMID:
16025398
[PubMed - indexed for MEDLINE]
16.

Reliability and validity of the Biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements.

Drouin JM, Valovich-mcLeod TC, Shultz SJ, Gansneder BM, Perrin DH.

Eur J Appl Physiol. 2004 Jan;91(1):22-9. Epub 2003 Sep 24.

PMID:
14508689
[PubMed - indexed for MEDLINE]
17.

Hypocalcemic hypercalciuria during vitamin D and dihydrotachysterol therapy of hypoparathyroidism.

LITVAK J, MOLDAWER MP, FORBES AP, HENNEMAN PH.

J Clin Endocrinol Metab. 1958 Mar;18(3):246-52. No abstract available.

PMID:
13513723
[PubMed - OLDMEDLINE]
18.

Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr.

J Clin Endocrinol Metab. 2003 Sep;88(9):4214-20.

PMID:
12970289
[PubMed - indexed for MEDLINE]
19.

Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women.

Tashjian AH Jr, Chabner BA.

J Bone Miner Res. 2002 Jul;17(7):1151-61. Review. No abstract available.

PMID:
12096828
[PubMed - indexed for MEDLINE]
20.

ATS statement: guidelines for the six-minute walk test.

ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.

Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. No abstract available.

PMID:
12091180
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk